Evidence map›Paper›PMID 31632976›Full record

ArticleFrontiers in medicine2019

Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.

Tara Sigdel, Mark Nguyen, Juliane Liberto, Dejan Dobi, Henrik Junger, Flavio Vincenti, Zoltan Laszik, Minnie M Sarwal

Abstract read
In one paragraph

Article in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  5. Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  6. Article
  7. Article
  8. T Cells With ActivatedFrontiers in immunology · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.International journal of molecular sciences · 2020
    Review
  15. Novel In Situ Hybridization and Multiplex Immunofluorescence Technology Combined With Whole-slide Digital Image Analysis in Kidney Transplantation.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tara SigdelDepartment of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Mark NguyenDepartment of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Juliane LibertoDepartment of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Dejan DobiDepartment of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Henrik JungerDepartment of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Flavio VincentiDepartment of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Zoltan LaszikDepartment of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Minnie M SarwalDepartment of Surgery, University of California, San Francisco, San Francisco, CA, United States.

Funding

Novel Therapies to Modulate the Inflammatory Alloresponse in Renal GraftsU01AI113362 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VINCENTI, FLAVIO · 2014 to 2023
$15.2M
Academic Training Program in NephrologyT32DK007219 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSU, CHI-YUAN · 1986 to 2022
$7.3M
Multiplex in situ gene expression and phenotypical profiling of inflamed tissuesU24AI118675 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LASZIK, ZOLTAN, TANG, QIZHI · 2015 to 2019
$2.0M
Drug Repositioning in Diabetic NephropathyR21TR001761 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SARWAL, MINNIE M · 2016 to 2018
$634k
NCATS NIH HHS R21 TR001761NIAID NIH HHS U01 AI113362NIAID NIH HHS U24 AI118675NIDDK NIH HHS T32 DK007219
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute rejectionbiomarkerFFPEkidney transplantationtranscriptomics analysis

Identifiers

PMID31632976
PMCPMC6781675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.